Clinical trial
Prospective, Multicenter, Single-group Clinical Trial Evaluating the Safety and Effectiveness of ShockPulse-10 in the Treatment of Coronary Artery Calcification
NCT06711822 is registered in ClinicalTrials.gov with Keya Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Single-group Clinical Trial Evaluating the Safety and Effectiveness of ShockPulse-10 in the Treatment of Coronary Artery Calcification
- Lead sponsor
- Keya Medical
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2024
- Completion date
- December 30, 2025
- Enrollment
- 205 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
calcification; heart, coronary arterial disease (cad)